US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist

1.480
-0.030-1.99%

Close Nov 29 13:00 ET

78.06MMarket Cap-498P/E (TTM)

ALX Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

18.56%-25.38M

16.22%-26.57M

-36.34%-37.92M

-46.11%-130.36M

-91.98%-39.68M

-0.89%-31.16M

-86.56%-31.71M

-34.55%-27.82M

-31.02%-89.22M

-18.18%-20.67M

Net income from continuing operations

39.78%-30.71M

-15.34%-39.4M

-17.88%-35.58M

-30.23%-160.81M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-47.95%-123.48M

-7.99%-30.71M

Operating gains losses

--0

--10K

----

Depreciation and amortization

7.18%224K

6.28%220K

0.47%214K

144.44%836K

97.14%207K

120.00%209K

146.43%207K

267.24%213K

570.59%342K

208.82%105K

Other non cash items

41.67%527K

27.17%468K

40.16%513K

30.31%1.52M

18.18%416K

23.18%372K

87.76%368K

15.09%366K

-78.47%1.17M

-92.91%352K

Change In working capital

-109.36%-1.32M

328.81%6.21M

-148.20%-8.56M

-15.77%8.3M

-91.67%331K

881.42%14.13M

-127.67%-2.71M

-62.26%-3.45M

344.60%9.85M

1,393.61%3.97M

-Change in prepaid assets

298.04%4.65M

26.77%-1.56M

-2,749.41%-4.5M

12.53%-1.29M

165.52%3.02M

2.90%-2.35M

-254.45%-2.13M

110.78%170K

11.19%-1.48M

199.21%1.14M

-Change in payables and accrued expense

-133.44%-5.75M

355.65%6.47M

22.39%-3.57M

-8.47%10.58M

-73.11%527K

1,990.51%17.18M

-129.08%-2.53M

-7,183.08%-4.6M

44.14%11.55M

16.95%1.96M

-Change in other current assets

-67.72%255K

-21.44%1.77M

-87.34%149K

82.13%1.37M

-380.14%-2.85M

1,449.02%790K

224,900.00%2.25M

471.29%1.18M

107.75%750K

4.74%1.02M

-Change in other current liabilities

68.11%-478K

-57.24%-467K

-229.84%-630K

-140.84%-2.35M

-159.57%-366K

-467.80%-1.5M

-7.61%-297K

35.47%-191K

-39.97%-977K

94.89%-141K

Cash from discontinued investing activities

Operating cash flow

18.56%-25.38M

16.22%-26.57M

-36.34%-37.92M

-46.11%-130.36M

-91.98%-39.68M

-0.89%-31.16M

-86.56%-31.71M

-34.55%-27.82M

-31.02%-89.22M

-18.18%-20.67M

Investing cash flow

Cash flow from continuing investing activities

100.49%25.69M

-85.40%907K

-37.41%26.47M

118.97%44.66M

-252.31%-16.67M

-6.43%12.82M

108.16%6.21M

123.00%42.3M

-4,681.96%-235.42M

342.19%10.94M

Net PPE purchase and sale

-111.44%-149K

94.82%-90K

78.55%-148K

10.72%-1.27M

61.95%-148K

778.65%1.3M

-576.65%-1.74M

-17.15%-690K

-114.26%-1.43M

-49.04%-389K

Net intangibles purchase and sale

----

--0

----

--0

----

Net investment purchase and sale

124.48%25.84M

-87.46%997K

-38.07%26.62M

119.63%45.93M

-245.78%-16.52M

-17.10%11.51M

110.48%7.95M

123.45%42.99M

---233.99M

--11.33M

Cash from discontinued investing activities

Investing cash flow

100.49%25.69M

-85.40%907K

-37.41%26.47M

118.97%44.66M

-252.31%-16.67M

-6.43%12.82M

108.16%6.21M

123.00%42.3M

-4,681.96%-235.42M

342.19%10.94M

Financing cash flow

Cash flow from continuing financing activities

326.13%251K

7,816.03%27.15M

2,984.11%3.09M

501.33%59.29M

523.19%59.17M

18.38%-111K

-18.72%343K

-233.75%-107K

298.87%9.86M

1,711.83%9.49M

Net issuance payments of debt

-222.52%-358K

-103.74%-218K

-63.55%-175K

-104.04%-388K

-100.64%-63K

21.28%-111K

-205.71%-107K

-1.90%-107K

3,520.64%9.61M

9,612.50%9.89M

Net common stock issuance

--75K

--26.2M

--3.02M

--58.89M

--0

----

Proceeds from stock option exercised by employees

--534K

159.33%1.17M

--237K

-12.29%792K

33.59%342K

--0

-1.53%450K

--0

-67.20%903K

-59.24%256K

Net other financing activities

----

---655K

----

Cash from discontinued financing activities

Financing cash flow

326.13%251K

7,816.03%27.15M

2,984.11%3.09M

501.33%59.29M

523.19%59.17M

18.38%-111K

-18.72%343K

-233.75%-107K

298.87%9.86M

1,711.83%9.49M

Net cash flow

Beginning cash position

-59.06%15.6M

-77.70%14.11M

-54.03%22.47M

-86.56%48.89M

-60.00%19.65M

-42.65%38.11M

-60.25%63.26M

-86.56%48.89M

-16.25%363.67M

-87.25%49.12M

Current changes in cash

103.08%568K

105.94%1.49M

-158.20%-8.37M

91.61%-26.42M

1,316.38%2.82M

-6.53%-18.46M

72.87%-25.16M

107.03%14.37M

-346.17%-314.78M

98.92%-232K

End cash Position

-17.72%16.17M

-59.06%15.6M

-77.70%14.11M

-54.03%22.47M

-60.00%19.65M

-42.65%38.11M

-60.25%63.26M

-86.56%48.89M

Free cash flow

14.51%-25.53M

20.31%-26.66M

-33.56%-38.07M

-45.22%-131.64M

-89.13%-39.83M

3.92%-29.86M

-93.86%-33.45M

-34.06%-28.51M

-24.14%-90.65M

4.31%-21.06M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	18.56%-25.38M	16.22%-26.57M	-36.34%-37.92M	-46.11%-130.36M	-91.98%-39.68M	-0.89%-31.16M	-86.56%-31.71M	-34.55%-27.82M	-31.02%-89.22M	-18.18%-20.67M
Net income from continuing operations	39.78%-30.71M	-15.34%-39.4M	-17.88%-35.58M	-30.23%-160.81M	-48.07%-45.47M	-44.37%-50.99M	-3.76%-34.16M	-23.03%-30.18M	-47.95%-123.48M	-7.99%-30.71M
Operating gains losses	--0	--0	--10K	----	----	----	----	----	----	----
Depreciation and amortization	7.18%224K	6.28%220K	0.47%214K	144.44%836K	97.14%207K	120.00%209K	146.43%207K	267.24%213K	570.59%342K	208.82%105K
Other non cash items	41.67%527K	27.17%468K	40.16%513K	30.31%1.52M	18.18%416K	23.18%372K	87.76%368K	15.09%366K	-78.47%1.17M	-92.91%352K
Change In working capital	-109.36%-1.32M	328.81%6.21M	-148.20%-8.56M	-15.77%8.3M	-91.67%331K	881.42%14.13M	-127.67%-2.71M	-62.26%-3.45M	344.60%9.85M	1,393.61%3.97M
-Change in prepaid assets	298.04%4.65M	26.77%-1.56M	-2,749.41%-4.5M	12.53%-1.29M	165.52%3.02M	2.90%-2.35M	-254.45%-2.13M	110.78%170K	11.19%-1.48M	199.21%1.14M
-Change in payables and accrued expense	-133.44%-5.75M	355.65%6.47M	22.39%-3.57M	-8.47%10.58M	-73.11%527K	1,990.51%17.18M	-129.08%-2.53M	-7,183.08%-4.6M	44.14%11.55M	16.95%1.96M
-Change in other current assets	-67.72%255K	-21.44%1.77M	-87.34%149K	82.13%1.37M	-380.14%-2.85M	1,449.02%790K	224,900.00%2.25M	471.29%1.18M	107.75%750K	4.74%1.02M
-Change in other current liabilities	68.11%-478K	-57.24%-467K	-229.84%-630K	-140.84%-2.35M	-159.57%-366K	-467.80%-1.5M	-7.61%-297K	35.47%-191K	-39.97%-977K	94.89%-141K
Cash from discontinued investing activities
Operating cash flow	18.56%-25.38M	16.22%-26.57M	-36.34%-37.92M	-46.11%-130.36M	-91.98%-39.68M	-0.89%-31.16M	-86.56%-31.71M	-34.55%-27.82M	-31.02%-89.22M	-18.18%-20.67M
Investing cash flow
Cash flow from continuing investing activities	100.49%25.69M	-85.40%907K	-37.41%26.47M	118.97%44.66M	-252.31%-16.67M	-6.43%12.82M	108.16%6.21M	123.00%42.3M	-4,681.96%-235.42M	342.19%10.94M
Net PPE purchase and sale	-111.44%-149K	94.82%-90K	78.55%-148K	10.72%-1.27M	61.95%-148K	778.65%1.3M	-576.65%-1.74M	-17.15%-690K	-114.26%-1.43M	-49.04%-389K
Net intangibles purchase and sale	----	----	----	--0	----	----	----	----	--0	----
Net investment purchase and sale	124.48%25.84M	-87.46%997K	-38.07%26.62M	119.63%45.93M	-245.78%-16.52M	-17.10%11.51M	110.48%7.95M	123.45%42.99M	---233.99M	--11.33M
Cash from discontinued investing activities
Investing cash flow	100.49%25.69M	-85.40%907K	-37.41%26.47M	118.97%44.66M	-252.31%-16.67M	-6.43%12.82M	108.16%6.21M	123.00%42.3M	-4,681.96%-235.42M	342.19%10.94M
Financing cash flow
Cash flow from continuing financing activities	326.13%251K	7,816.03%27.15M	2,984.11%3.09M	501.33%59.29M	523.19%59.17M	18.38%-111K	-18.72%343K	-233.75%-107K	298.87%9.86M	1,711.83%9.49M
Net issuance payments of debt	-222.52%-358K	-103.74%-218K	-63.55%-175K	-104.04%-388K	-100.64%-63K	21.28%-111K	-205.71%-107K	-1.90%-107K	3,520.64%9.61M	9,612.50%9.89M
Net common stock issuance	--75K	--26.2M	--3.02M	--58.89M	--58.89M	--0	--0	--0	--0	----
Proceeds from stock option exercised by employees	--534K	159.33%1.17M	--237K	-12.29%792K	33.59%342K	--0	-1.53%450K	--0	-67.20%903K	-59.24%256K
Net other financing activities	----	----	----	----	----	----	----	----	---655K	----
Cash from discontinued financing activities
Financing cash flow	326.13%251K	7,816.03%27.15M	2,984.11%3.09M	501.33%59.29M	523.19%59.17M	18.38%-111K	-18.72%343K	-233.75%-107K	298.87%9.86M	1,711.83%9.49M
Net cash flow
Beginning cash position	-59.06%15.6M	-77.70%14.11M	-54.03%22.47M	-86.56%48.89M	-60.00%19.65M	-42.65%38.11M	-60.25%63.26M	-86.56%48.89M	-16.25%363.67M	-87.25%49.12M
Current changes in cash	103.08%568K	105.94%1.49M	-158.20%-8.37M	91.61%-26.42M	1,316.38%2.82M	-6.53%-18.46M	72.87%-25.16M	107.03%14.37M	-346.17%-314.78M	98.92%-232K
End cash Position	-17.72%16.17M	-59.06%15.6M	-77.70%14.11M	-54.03%22.47M	-54.03%22.47M	-60.00%19.65M	-42.65%38.11M	-60.25%63.26M	-86.56%48.89M	-86.56%48.89M
Free cash flow	14.51%-25.53M	20.31%-26.66M	-33.56%-38.07M	-45.22%-131.64M	-89.13%-39.83M	3.92%-29.86M	-93.86%-33.45M	-34.06%-28.51M	-24.14%-90.65M	4.31%-21.06M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data